Acute monocytic leukemia carrying trisomy 8 in a chronic myeloid leukemia patient who had achieved a deep molecular response with nilotinib

Myeloid Leukemia ◽

Acute Monocytic Leukemia ◽

Molecular Response ◽

Monocytic Leukemia ◽

Trisomy 8 ◽

Leukemia Patient ◽

Deep Molecular Response

Long‑lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib

Oncology Letters ◽

10.3892/ol.2017.7720 ◽

2017 ◽

Cited By ~ 3

Author(s):

Tatsuro Jo ◽

Kazuhiro Noguchi ◽

Shizuka Hayashi ◽

Sadaharu Irie ◽

Risa Hayase ◽

...

Keyword(s):

Cellular Immunity ◽

Myeloid Leukemia ◽

Molecular Response ◽

Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature

Leukemia Research ◽

10.1016/j.leukres.2010.03.019 ◽

2010 ◽

Vol 34 (9) ◽

pp. e229-e231 ◽

Cited By ~ 1

Author(s):

Dariusz Kata ◽

Katarzyna Mrówka-Kata ◽

Marek Seweryn ◽

Jacek Pająk ◽

Jacek Najda ◽

...

Keyword(s):

Case Report ◽

Testicular Cancer ◽

Myeloid Leukemia ◽

Molecular Response ◽

Review Of The Literature ◽

Decision letter for "A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5) – AGMT_CML 1"

10.1002/hon.2786/v2/decision1 ◽

2020 ◽

Keyword(s):

Myeloid Leukemia ◽

Phase 1 ◽

Chronic Phase ◽

Molecular Response ◽

Imatinib Treatment ◽

Phase 1 Study ◽

Deep Molecular Response

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Hematology Transfusion and Cell Therapy ◽

10.1016/j.htct.2021.04.007 ◽

2021 ◽

Author(s):

Selin Küçükyurt ◽

Alihan Kelezoğlu ◽

Tuğrul Elverdi ◽

Deniz Özmen ◽

Muhlis Cem Ar ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Maintenance Therapy ◽

Myeloid Leukemia ◽

Blast Crisis ◽

Hematopoietic Stem ◽

Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

Leukemia & Lymphoma ◽

10.1080/10428190701671044 ◽

2007 ◽

Vol 48 (12) ◽

pp. 2461-2464 ◽

Cited By ~ 15

Author(s):

Ricardo García-Muñoz ◽

Alicia Galar ◽

Cristina Moreno ◽

Paula Rodríguez-Otero ◽

Elena Panizo-Morgado ◽

...

Keyword(s):

Myeloid Leukemia ◽

Parvovirus B19 ◽

Acute Infection ◽

Leukemia Patient ◽

Herpesvirus 6

Budget Impact of Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia With Sustained Deep Molecular Response

Value in Health ◽

10.1016/j.jval.2020.11.010 ◽

2021 ◽

Author(s):

Cyril Astrugue ◽

Antoine Bénard ◽

Pauline Bosco-Levy ◽

Stéphanie Dulucq ◽

Magali Rouyer ◽

...

Keyword(s):

Tyrosine Kinase Inhibitor Discontinuation

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Myeloid Leukemia ◽

Budget Impact ◽

Kinase Inhibitor ◽

Molecular Response ◽

Deep Molecular Response ◽

Digital PCR can provide improved BCR-ABL1 detection in chronic myeloid leukemia patients in deep molecular response and sensitivity of standard quantitative methods using EAC assays

Practical Laboratory Medicine ◽

10.1016/j.plabm.2021.e00210 ◽

2021 ◽

Vol 25 ◽

pp. e00210

Author(s):

Dagmar Smitalova ◽

Dana Dvorakova ◽

Zdenek Racil ◽

Marianna Romzova

Keyword(s):

Myeloid Leukemia ◽

Quantitative Methods ◽

Digital Pcr ◽

Molecular Response ◽

Deep Molecular Response

Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate

Journal of Cosmetic and Laser Therapy ◽

10.1080/14764172.2018.1525745 ◽

2018 ◽

Vol 21 (4) ◽

pp. 243-244

Author(s):

Yegyu Sung ◽

Min Hee Kim ◽

Eujin Cho

Keyword(s):

Hyaluronic Acid ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Filler Injection ◽

Targeting bcr-abl Transcripts with siRNAs in an Imatinib-Resistant Chronic Myeloid Leukemia Patient: Challenges and Future Directions

RNA Interference - Methods in Molecular Biology ◽

10.1007/978-1-4939-1538-5_17 ◽

2014 ◽

pp. 277-292 ◽

Cited By ~ 5

Author(s):

Michael Koldehoff

Keyword(s):

Myeloid Leukemia ◽

Future Directions ◽

Leukemia Patient ◽

Imatinib Resistant

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR 4.5 ): The phase 2, multicenter N‐Road study

Cancer Medicine ◽

10.1002/cam4.3034 ◽

2020 ◽

Vol 9 (11) ◽

pp. 3742-3751

Author(s):

Kaichi Nishiwaki ◽

Kei‐ji Sugimoto ◽

Shigehisa Tamaki ◽

Junichi Hisatake ◽

Hisayuki Yokoyama ◽

...

Keyword(s):

Treatment Strategy ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Molecular Response ◽

Phase 2 ◽

Newly Diagnosed ◽

Deep Molecular Response ◽

Road Study ◽

Optimal Treatment Strategy